BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 11073163)

  • 1. Proteasome inhibitors induced caspase-dependent apoptosis and accumulation of p21WAF1/Cip1 in human immature leukemic cells.
    Naujokat C; Sezer O; Zinke H; Leclere A; Hauptmann S; Possinger K
    Eur J Haematol; 2000 Oct; 65(4):221-36. PubMed ID: 11073163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of p53 and p21Waf1 expression on G2/M phase arrest of colorectal carcinoma HCT116 cells to proteasome inhibitors.
    Kim OH; Lim JH; Woo KJ; Kim YH; Jin IN; Han ST; Park JW; Kwon TK
    Int J Oncol; 2004 Apr; 24(4):935-41. PubMed ID: 15010833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of proteasome function induced apoptosis in gastric cancer.
    Fan XM; Wong BC; Wang WP; Zhou XM; Cho CH; Yuen ST; Leung SY; Lin MC; Kung HF; Lam SK
    Int J Cancer; 2001 Aug; 93(4):481-8. PubMed ID: 11477551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition.
    An WG; Hwang SG; Trepel JB; Blagosklonny MV
    Leukemia; 2000 Jul; 14(7):1276-83. PubMed ID: 10914553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome inhibitors induce p53/p21-independent apoptosis in human glioma cells.
    Wagenknecht B; Hermisson M; Eitel K; Weller M
    Cell Physiol Biochem; 1999; 9(3):117-25. PubMed ID: 10494025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
    Malashicheva AB; Kislyakova TV; Aksenov ND; Osipov KA; Pospelov VA
    Oncogene; 2000 Aug; 19(34):3858-65. PubMed ID: 10951579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.
    Zhang XM; Lin H; Chen C; Chen BD
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasome inhibitors induce mitochondria-independent apoptosis in human glioma cells.
    Kitagawa H; Tani E; Ikemoto H; Ozaki I; Nakano A; Omura S
    FEBS Lett; 1999 Jan; 443(2):181-6. PubMed ID: 9989601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactacystin, a proteasome inhibitor, potentiates the apoptotic effect of parthenolide, an inhibitor of NFkappaB activation, on drug-resistant mouse leukemia L1210 cells.
    Cory AH; Cory JG
    Anticancer Res; 2002; 22(6C):3805-9. PubMed ID: 12552998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53-induced apoptosis in the human T-ALL cell line CCRF-CEM.
    Geley S; Hartmann BL; Hattmannstorfer R; Löffler M; Ausserlechner MJ; Bernhard D; Sgonc R; Strasser-Wozak EM; Ebner M; Auer B; Kofler R
    Oncogene; 1997 Nov; 15(20):2429-37. PubMed ID: 9395239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cycling B-CLL cells are highly susceptible to inhibition of the proteasome: involvement of p27, early D-type cyclins, Bax, and caspase-dependent and -independent pathways.
    Bogner C; Schneller F; Hipp S; Ringshausen I; Peschel C; Decker T
    Exp Hematol; 2003 Mar; 31(3):218-25. PubMed ID: 12644019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p21WAF1 prevents down-modulation of the apoptotic inhibitor protein c-IAP1 and inhibits leukemic apoptosis.
    Steinman RA; Johnson DE
    Mol Med; 2000 Sep; 6(9):736-49. PubMed ID: 11071269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of p53 in cell cycle regulation and apoptosis following exposure to proteasome inhibitors.
    Chen F; Chang D; Goh M; Klibanov SA; Ljungman M
    Cell Growth Differ; 2000 May; 11(5):239-46. PubMed ID: 10845424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p27Kip1 accumulation by inhibition of proteasome function induces apoptosis in oral squamous cell carcinoma cells.
    Kudo Y; Takata T; Ogawa I; Kaneda T; Sato S; Takekoshi T; Zhao M; Miyauchi M; Nikai H
    Clin Cancer Res; 2000 Mar; 6(3):916-23. PubMed ID: 10741716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of etoposide-induced apoptosis by proteasome inhibitors in a human leukemic cell line but not in fresh acute leukemia blasts. A differential role of NF-kappab activation.
    Watanabe K; Kubota M; Hamahata K; Lin Y; Usami I
    Biochem Pharmacol; 2000 Sep; 60(6):823-30. PubMed ID: 10930537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat-shock protein 70 antisense oligomers enhance proteasome inhibitor-induced apoptosis.
    Robertson JD; Datta K; Biswal SS; Kehrer JP
    Biochem J; 1999 Dec; 344 Pt 2(Pt 2):477-85. PubMed ID: 10567231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasome inhibitor-induced apoptosis of B-chronic lymphocytic leukaemia cells involves cytochrome c release and caspase activation, accompanied by formation of an approximately 700 kDa Apaf-1 containing apoptosome complex.
    Almond JB; Snowden RT; Hunter A; Dinsdale D; Cain K; Cohen GM
    Leukemia; 2001 Sep; 15(9):1388-97. PubMed ID: 11516099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human THP-1 monocytic leukemic cells induced to undergo monocytic differentiation by bryostatin 1 are refractory to proteasome inhibitor-induced apoptosis.
    Chen C; Lin H; Karanes C; Pettit GR; Chen BD
    Cancer Res; 2000 Aug; 60(16):4377-85. PubMed ID: 10969781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteasome inhibitors induce growth inhibition and apoptosis in myeloma cell lines and in human bone marrow myeloma cells irrespective of chromosome 13 deletion.
    Zavrski I; Naujokat C; Niemöller K; Jakob C; Heider U; Langelotz C; Fleissner C; Eucker J; Possinger K; Sezer O
    J Cancer Res Clin Oncol; 2003 Jul; 129(7):383-91. PubMed ID: 12851815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-kappaB-dependent process.
    Dai Y; Rahmani M; Grant S
    Oncogene; 2003 Oct; 22(46):7108-22. PubMed ID: 14562039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.